Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Sarcoma and Rare Cancers Congress 2025

Methodology (tumour agnostic)

The ESMO Tumour-Agnostic Classifier as part of tumour-agnostic drug development

Date

21 Mar 2025

Session

Methodology (tumour agnostic)

Topics

Clinical Research;  Genetic and Genomic Testing;  Statistics

Tumour Site

Presenters

Christoph Benedikt Westphalen

Authors

C.B. Westphalen

Author affiliations

  • Medical Oncology Department, LMU Klinikum der Universität München, 81377 - Munich/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Q&A and discussion

Session: Methodology (tumour agnostic)

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.